FDA Approves Second OTC Naloxone Spray for Opioid Overdose

ReVive is the second OTC overdose reversal agent approved by the FDA and the first to be received by a nonprofit pharmaceutical company.

Related Keywords

United States ,Americans ,Michael Hufford ,Robertm Califf ,Purdue Pharma ,Harm Reduction Therapeutics Inc ,Drug Administration ,Centers For Disease ,Harm Reduction Therapeutics ,Disease Control ,Emergent Biosolutions ,Opioids ,Addiction ,Overdose ,Rug Overdose ,Centers For Disease Control And Prevention Cdc ,Us Food And Drug Administration ,Nited States Food And Drug Administration ,Fda ,Grant ,